DAB2IP in cancer-Reference-Cited by-同舟云学术

DAB2IP in cancer

Published:2015-12-08 Issue:4 Volume:7 Page:3766-3776
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Liu Liang¹²,Xu Cong³,Hsieh Jer-Tsong⁴,Gong Jianping¹²,Xie Daxing¹²

Affiliation:

1. Tongji Cancer Research Institute, Tongji Hospital, Tongji Medical College in Huazhong University of Science and Technology, Wuhan, Hubei 430030, China

2. Department of Gastrointestinal Surgery, Tongji Hospital, Tongji Medical College in Huazhong University of Science and Technology, Wuhan, Hubei 430030, China

3. Department of Gastroenterology, Tongji Hospital, Tongji Medical College in Huazhong University of Science and Technology, Wuhan, Hubei 430030, China

4. Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Competing endogenous RNAs regulatory crosstalk networks: The messages from the RNA world to signaling pathways directing cancer stem cell development;Heliyon;2024-08

2. Immunoexpression Patterns of Megalin, Cubilin, Caveolin-1, Gipc1 and Dab2IP in the Embryonic and Postnatal Development of the Kidneys in Yotari (Dab1−/−) Mice;Biomedicines;2024-07-11

3. An update on the tumor-suppressive functions of the RasGAP protein DAB2IP with focus on therapeutic implications;Cell Death & Differentiation;2024-06-20

4. DAB2IP inhibits glucose uptake by modulating HIF-1α ubiquitination under hypoxia in breast cancer;Oncogenesis;2024-06-11

5. The scaffold protein disabled 2 (DAB2) and its role in tumor development and progression;Molecular Biology Reports;2024-06-01